Halozyme Therapeutics COO Cortney Caudill Sells Shares for Tax Obligations
I'm PortAI, I can summarize articles.
Reporter NameCaudill CortneyRelationshipSVP, CHIEF OPERATING OFFICER, 10% OwnerTypeSellAmount$277,904SEC FilingForm 4Cortney Caudill, SVP and Chief Operating Officer of Halozyme Therapeutics, and a 10% owner, sold 4,263 shares of common stock on November 1, 2025, at a price of $65.19 per share, totaling $277,904. The sale was conducted to fulfill tax withholding obligations related to the vesting of restricted stock units. Following the transaction, Caudill directly owns 12,737 shares of Halozyme Therapeutics.SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - Form 4 - Dec. 19, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments